Announcement on the Removal of Delisting Risk Warning and Continuation of Other Risk Warnings, along with Temporary Suspension of Trading
The Shanghai Stock Exchange agreed on January 12, 2026 to lift the delisting risk warning imposed on the stocks of NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD. and continue to implement other risk warnings. The company’s stocks will be suspended for one day starting from the opening on January 13, 2026, and will resume trading starting from the opening on January 14, 2026. The company's stocks are still traded on the risk warning board, and the daily price fluctuation limit remains at 5%. The stock abbreviation will change from "*NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD." to "NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."; the stock code remains "600165".
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
The Shanghai Stock Exchange agreed on January 12, 2026 to lift the delisting risk warning imposed on the stocks of NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD. and continue to implement other risk warnings. The company’s stocks will be suspended for one day starting from the opening on January 13, 2026, and will resume trading starting from the opening on January 14, 2026. The company's stocks are still traded on the risk warning board, and the daily price fluctuation limit remains at 5%. The stock abbreviation will change from "*NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD." to "NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD."; the stock code remains "600165".
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment